Using natural biologics to decompress pain inducing lesions, edemas, cysts, and insufficiency fractures by introducing high quality autologous biologic material to accelerate and promote healing of damaged subchondral bone and degenerated cartilage.
Core decompression will relieve edema and allow healthy blood flow back into the area. Bone Marrow Aspirate Concetrate – rich stem cells and growth factors – are then injected into the fracture/lesion which then signals osteogenic and osteoinductive potential, resulting in the acceleration of new bone formation.
Osteoarthritis can be viewed as a group of overlapping disorders, which results mainly in functional joint failure. Symptomatic OA is linked with bone marrow lesions and BMLs patterns from magnetic resonance images (MRI) have been linked with pain and cartilage degeneration.
When damage persistently exceeds repair or the bone is unable to heal with periods of rest or unloading, a chronic bone marrow edema lesion (BME/BML) develops.
There is a correlation of chronic bone marrow lesions/edemas with knee pain and progression of osteoarthritis. The IO-Core osteochondral defect procedure provides the highest quality autologous biologics and technique to treating patients who suffer from debilitating pain caused by bone marrow lesions, edemas, cysts, and insufficiency fractures associated with acute and/or chronic injuries such as osteoarthritis.
Osteoarthritis (OA) is a common joint disease in which involves the “wear and tear” of the joints cartilage, ligaments, joint lining, and bone. OA is characterized by the breakdown of the cartilage (the cushion between the ends of each bone), deterioration of the ligaments and tendons as well as various degrees of inflammation of the joint lining. Symptoms of Osteoarthritis include pain and stiffness in the joint, cracking or grinding noises through joint movement and decreased function of the joint.